Ron Cohen, President and CEO at ACORDA THERAPEUTICS INC (ACOR), bought 20,000 shares at $16.95 ($339K) on 2017-06-16, disclosed to the SEC on 2017-06-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| ACOR | SELL | 2019-12-04 | $8K | — | Filing → |
| ACOR | SELL | 2018-12-06 | $75K | — | Filing → |
| ACOR | SELL | 2016-12-16 | $834K | — | Filing → |